Purity, disgust, and intent to receive the HPV vaccine

Not Applicable

Completed

• Conditions: Intent to receive HPV vaccine; Urological and Genital Diseases

• Registration Number: ISRCTN27393344
• Lead Sponsor: Emory University Rollins School of Public Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-01-18
• Study Completion: 2019-09-15
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 5049

Inclusion Criteria

1. Between 18 and 23 years of age (inclusive)
2. Resident of the United States
3. Has received no more than 2 doses of the HPV vaccine

Exclusion Criteria

1. Has completed the HPV vaccine series (3 or more doses)
2. Has already completed the survey

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intent to receive the HPV vaccine, measured once during a post-intervention survey administered immediately after the visual message has been reviewed by the participant. The method of measurement for the primary outcome is a single question asking if the participants intends to initiate (if they have received 0 HPV vaccine doses) or continue (if they have received 1-2 HPV vaccine doses) the HPV vaccine series.

Secondary Outcome Measures

Name	Time	Method
Clicks on a link helping to locate the nearest vaccine clinic, measured using embedded data in the online survey administered immediately after the visual message has been reviewed by the participant.